Menopausal hot flashes: A concise review
Open accessThe DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Abstract
Hot flashes (HFs), defined as transient sensations of heat, sweating, flushing, anxiety, and chills lasting for 1-5 min, constitute one of the most common symptoms of menopause among women though only a few seek treatment for these. The basis of HFs lies in abnormal hypothalamic thermoregulatory control resulting in abnormal vasodilatory response to minor elevations of core body temperature. Recent data suggest an important role for calcitonin gene-related peptide, hypothalamic kisspeptin, neurokinin B and dynorphin signal system, serotonin, norepinephrine in causation of HFs in addition to estrogen deficiency which plays a cardinal role. The mainstay of treatment includes hormonal replacement therapy, selective serotonin, and norepinephrine reuptake inhibitors in addition to lifestyle modification. In this review, we address common issues related to menopause HFs and suggest a stepwise approach to their management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The GPR54 Gene as a Regulator of Puberty
Seminara, S. B., Messager, S., Chatzidaki, E. E., Thresher, R. R., Acierno, J. S., Shagoury, J. K., Bo-Abbas, Y., Kuohung, W., Schwinof, K. M., Hendrick, A. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035322 · Cited by 2,557
Treatment of symptoms of the menopause: an Endocrine Society Clinical Practice Guideline
Stuenkel, C. A., Davis, S. R., Gompel, A., Lumsden, M. A., Murad, M. H., Pinkerton, J. V., & Santen, R. J. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2236 · Cited by 884 · cited 1×
“For women, who have contraindications or cannot tolerate HRT, nonhormonal drugs are used for the management of HFs.[40,54] The various nonhormonal treatment options include.”
BackgroundGold, E. B. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.5.463 · Cited by 861 · cited 1×
“Among various factors reported to be associated with increase in incidence of HFs, a consistent association has been found only with obesity, African descent, lower socioeconomic status, presence of premenstrual syndrome, sedentary lifestyle, and smoking.[16,17] Recently, the role of genetic factors in causation of HF…”
BackgroundHot Flashes: Epidemiology and Physiology a
KRONENBERG, F. (1990) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1990.tb30316.x · Cited by 601
Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002978.pub2 · Cited by 543
Prospective evaluation of vitamin E for hot flashes in breast cancer survivors.
Barton, D. L., Loprinzi, C. L., Quella, S. K., Sloan, J. A., Veeder, M. H., Egner, J. R., Fidler, P., Stella, P. J., Swan, D. K., Vaught, N. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.2.495 · Cited by 403 · cited 1×
“[36] Other options which may be tried with some efficacy include Vitamin E in low doses, weight loss, and cognitive behavior therapy.[37,38]”
BackgroundFreedman, R. R. (2001) · American Journal of Human Biology · doi:10.1002/ajhb.1077 · Cited by 369 · cited 1×
“The various ways which often prove helpful include use of fans, lowering of room temperature, avoidance of triggers such as alcohol, spices, and use of clothes with are heat and sweat‐friendly.[36] Other options which may be tried with some efficacy include Vitamin E in low doses, weight loss, and cognitive behavior t…”
BackgroundRevisiting the duration of vasomotor symptoms of menopause: a meta-analysis
Politi, M. C., Schleinitz, M. D., & Col, N. F. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0655-4 · Cited by 244 · cited 1×
“[5] In another meta‐analysis (n = 35455), mean duration of HFs was estimated to be 4 years,[6] while two studies[8,9] found a median duration of Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India”
BackgroundBiochemical, metabolic, and vascular mechanisms in menopausal hot flashes
Freedman, R. R. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00137-x · Cited by 232 · cited 2×
“[21] These include (a) favorable response of HFs to selective serotonin reuptake inhibitors (SSRIs); (b) increased plasma levels of main brain metabolite of norepinephrine during HFs;[24] (c) reduction in HFs by Clonidine (α2 adrenergic antagonist), a drug which decreases brain norepinephrine levels;[25] and (d) Yohim…”
BackgroundDuration of vasomotor symptoms in middle-aged women: a longitudinal study
Col, N. F., Guthrie, J. R., Politi, M., & Dennerstein, L. (2009) · Menopause · doi:10.1097/gme.0b013e31818d414e · Cited by 194 · cited 1×
“2 years in one meta‐analysis.[5] In another meta‐analysis (n = 35455), mean duration of HFs was estimated to be 4 years,[6] while two studies[8,9] found a median duration of Department of Obstetrics and Gynecology, Postgraduate Institute of Medical Education and Research, Chandigarh, India”
Background
Cited by
Huang, D. R., Goodship, A., Webber, I., Alaa, A., Sasco, E. R., Hayhoe, B., & El-Osta, A. (2023) · BMC Women's Health · doi:10.1186/s12905-023-02506-w · Cited by 73
Karimi, L., Mokhtari Seghaleh, M., Khalili, R., & Vahedian-Azimi, A. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01653-w · Cited by 19
“Women may experience symptoms such as hot flashes [8], night sweats [9], mood swings, heart palpitations [10], bone pain [11], atrophy of the vagina and vulva [12, 13], and some other complications such as osteoporosis [14].”
BackgroundClinical hypnosis and cognitive behavioral therapy for hot flashes: a scoping review.
Muñiz, V., Padilla, V. J., Alldredge, C. T., & Elkins, G. (2025) · Women's Health Reports · doi:10.1089/whr.2024.0144 · Cited by 6
Metadata
- Authors
- Bansal, R., & Aggarwal, N.
- Venue
- Journal of Mid-life Health
- Publisher
- Medknow
- Published
- 2019
- Volume
- 10
- Issue
- 1
- Pages
- 6
- ISSN
- 0976-7800 (ISSN-L)
- OpenAlex
- W2932588638
- Cited by
- 103
- References
- 13
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.